jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Jan. 10, 2012

Dec. 17, 2018

jRCT1080221685

ZO-Y60 Phase III clinical trial

version:
date:

Zeria Pharmaceutical Co., Ltd.

03-5644-7053

Interventional

3

Patients with gasstrointestinal disease.
Out-patients who signed a written informed consent.
If patient age is under 20 years old, a written informed consent have to be obtained from both participant and his/her parent(s).

15age old over
64age old under

Both

Gastrointestinal disease

investigational material(s)
Generic name etc : ZO-Y60
INN of investigational material :
Therapeutic category code : 239 Other agents affecting digestive organs
Dosage and Administration for Investigational material : 3 capsules / day

ZERIA Pharmaceutical Co.,Ltd.
Institutional review board of Fukui Sogo Hospital

JapicCTI-121727

History of Changes

No Publication date
7 Dec. 17, 2018 (this page) Changes
6 April. 02, 2013 Detail Changes
5 April. 02, 2013 Detail Changes
4 July. 04, 2012 Detail Changes
3 July. 04, 2012 Detail Changes
2 Jan. 10, 2012 Detail Changes
1 Jan. 10, 2012 Detail